Kyowa Kirin
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Crysvita | Burosumab | 2018-04-17 | ||
| Fareston | Toremifene | 1997-05-29 | ||
| Moventig | Naloxegol | 2014-12-07 | 2024-2032 | |
| Nourianz | Istradefylline | 2019-08-27 | 2023-2027 | |
| Pecfent | Fentanyl | 2010-08-31 | 2024-2033 | |
| Poteligeo | Mogamulizumab | 2018-08-08 | ||
| Sancuso | Granisetron | 2012-04-20 | 2024-2025 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use